Vor Biopharma Inc. (VOR) stock

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30

$19.42+0.10 (+0.52%)

Close on Nov 13, 2026Market cap $1.19BP/E –Yield –

Vor Biopharma gross margin

Gross margin is gross profit as a percentage of revenue.

Vor Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?